β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection

被引:0
|
作者
Hongen Li
Xiaoran Zhao
Jianfeng Wang
Yu Dong
Song Meng
Rui Li
Xiaodi Niu
Xuming Deng
机构
[1] Ministry of Education,Key Laboratory of Zoonosis, Department of Food Quality and Safety
[2] College of Veterinary Medicine,undefined
[3] Jilin University,undefined
[4] Institute of Biophysics,undefined
[5] CAS,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Pneumolysin is one of the major virulence factors elaborated by Streptococcus pneumoniae; this toxin is a member of the cholesterol-dependent cytolysins. Engagement of cholesterol induces the formation of a multi-subunit complex by pneumolysin that lyses host cells by forming pores on the membrane. Because pneumolysin released by bacteria which have been killed by conventional antibiotics is still active, agents capable of directly attacking the toxin are considered advantageous against antimicrobials in the treatment of S. pneumoniae infections. Here we found that the phytosterol, β-sitosterol, effectively protects against cell lysis caused by pneumolysin. This compound interacts with the toxin at Thr459 and Leu460, two sites important for being recognized by its natural ligand, cholesterol. Similar to cholesterol, β-sitosterol induces pneumolysin oligomerization. This compound also protects cells from damage by other cholesterol-dependent toxins. Finally, this compound protects mice against S. pneumoniae infection. Thus, β-sitosterol is a candidate for the development of anti-virulence agents against pathogens that rely on cholesterol-dependent toxins for successful infections.
引用
收藏
相关论文
共 50 条
  • [1] β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection
    Li, Hongen
    Zhao, Xiaoran
    Wang, Jianfeng
    Dong, Yu
    Meng, Song
    Li, Rui
    Niu, Xiaodi
    Deng, Xuming
    SCIENTIFIC REPORTS, 2015, 5
  • [2] The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection
    Cockeran, R
    Anderson, R
    Feldman, C
    CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (03) : 235 - 239
  • [3] Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection
    Lv, Qianghua
    Zhang, Peng
    Quan, Pusheng
    Cui, Mengyao
    Liu, Tianjiao
    Yin, Yunhou
    Chi, Gefu
    MICROBIAL PATHOGENESIS, 2020, 140
  • [4] The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae
    Paton, JC
    TRENDS IN MICROBIOLOGY, 1996, 4 (03) : 103 - 106
  • [5] Export Requirements of Pneumolysin in Streptococcus pneumoniae
    Price, Katherine E.
    Greene, Neil G.
    Camilli, Andrew
    JOURNAL OF BACTERIOLOGY, 2012, 194 (14) : 3651 - 3660
  • [6] Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro
    Zou, Yinuo
    Wang, Haiting
    Fang, Juan
    Sun, Hongxiang
    Deng, Xuming
    Wang, Jianfeng
    Deng, Yanhong
    Chi, Gefu
    MICROBIAL PATHOGENESIS, 2023, 185
  • [7] Pneumolysin Localizes to the Cell Wall of Streptococcus pneumoniae
    Price, Katherine E.
    Camilli, Andrew
    JOURNAL OF BACTERIOLOGY, 2009, 191 (07) : 2163 - 2168
  • [8] DISTRIBUTION AND EXPRESSION OF PNEUMOLYSIN IN STREPTOCOCCUS-PNEUMONIAE
    LI, J
    TAI, S
    NGUYEN, N
    LEE, C
    FASEB JOURNAL, 1991, 5 (06): : A1626 - A1626
  • [9] Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers
    Sheng, Qiushuang
    Hou, Xiaoning
    Wang, Nan
    Liu, Minda
    Zhu, Haoyu
    Deng, Xuming
    Liang, Xiaoying
    Chi, Gefu
    MOLECULES, 2022, 27 (16):
  • [10] Human IgG to Pneumolysin (PLY) is protective in vivo against infection by Streptococcus pneumoniae (Spn)
    Musher, DM
    Phan, HM
    Mediwala, R
    Baughn, RE
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 233 - 233